Sustainability is an essential aspect of everything we do. Our aim is to engage all our leaders and employees in our journey to embed environmental, social, and governance considerations into our daily operations. To achieve this, we have a clear vision and strategy that includes collaborative work in global, cross-functional teams, with a strong commitment to diversity and inclusion.
SUSTAINABILITY as part of who we are
- We provide solutions to global musculoskeletal healthcare challenges by ensuring access to innovative and effective products.
- We take a proactive approach to sustainability by setting scienced based targets and engaging with suppliers and customers across our value chain.
- We involve all employees and strive for integration of sustainability as a natural part of our business.
Our focus in 2023
- Further strengthen our ability to meet sustainability expectations from healthcare institutions, payers, investors and other stakeholders
- Prepare for the Corporate Sustainability Reporting Directive (CSRD)
- Commit to the Science Based Target Initiative (SBTi) and set science based targets, scope 1 and 2.
GOVERNANCE AND RESPONSIBILITY
The group’s sustainability efforts are overseen by the Board of Directors, which holds ultimate responsibility for the company’s operations. The Board has established policies and guidelines related to environmental aspects as well as a Code of Conduct that applies to all employees and which involves anti-bribery, anti-corruption and human rights practices.
To ensure effective implementation of the Board’s decisions, the CEO is responsible for driving progress, with Kristina Ingvar, Executive Vice President Quality Management & Regulatory Affairs, leading the group’s sustainability work within the management team. Additionally, there is a dedicated sustainability working group established within the company to further support and advance our sustainability initiatives.
BONESUPPORT’S CODE OF CONDUCT
BONESUPPORT’s Code of Conduct defines our values and principles, providing business ethical guidance for leaders and employees.
All employees undergo yearly training in the code of conduct, ensuring they understand its contents. The code of conduct is reviewed on an ongoing basis and adopted annually by BONESUPPORT’s Board of Directors.
To promote transparency and accountability, a whistleblowing function is available to employees to report suspected violations of the code of conduct. To ensure independence and anonymity, BONESUPPORT has engaged an external party to handle all reporting and investigations related to the whistleblowing function.
At BONESUPPORT we believe in the development of effective and inclusive teams by incorporating culture and diversity practices into our way of working. We believe in fair compensation practices, and we are dedicated to ensuring that our employees are compensated in a manner that reflects the value they bring to our organization. To achieve this, our compensation framework considers factors such as job responsibilities, market standards, and internal equity.
Our recruitment process prioritizes diversity in all aspects, including age, gender, ethnicity, culture, and personality, a successful recipe to promote an open, productive, and innovative work environment. We also place a strong emphasis on our employees’ competences and development, and evaluate each team member’s performance based on both financial and qualitative metrics. The latter criteria align with the company’s overarching strategic objectives, which are broken down into specific targets for each function and individual. We strive to promote transparency in our compensation model and have bonus policies as well as defined practices of diversity and inclusion.
We are proud of the engagement and commitment of our employees which are reflected in the high scores we receive in leadership, engagement, culture, and eNPS in our quarterly pulse surveys.
BONESUPPORT works with medical technology, where good quality is a prerequisite for safe and efficient products. This includes fundamentals such as:
- We comply with international standards for medical devices
- We carry out inspections of contract manufacturers and other subcontractors on a regular basis
- We are regularly inspected by accredited bodies that certify the activities
- Our quality system is certified according to ISO 13485
OUR VIEW OF ANTIBIOTIC USE
Antimicrobial Resistance (AMR) is an increasing threat to global public health and collaboration is important to counteract this. BONESUPPORT is committed to the responsible use of antibiotics and supports antibiotic stewardship.
OUR VIEW OF ANIMAL TESTING
As part of research and development in the medical device industry, it is sometimes necessary to carry out experiments on animals, as this is requested by the responsible authorities. Strict ethical deliberations are made before animal testing is initiated or funded by BONESUPPORT.
Alternative methods, such as mathematical modelling or in vitro biological systems, are used if possible. If animal studies are deemed necessary, BONESUPPORT strives to involve as few animals as possible. The protocol is designed to be as gentle as possible for the animals and, in accordance with the legislation, the study protocol is always approved by an ethics committee. BONESUPPORT takes animal welfare very seriously.
BONESUPPORT works actively to reduce the group’s environmental impact. This applies to everything from small efforts in daily work, such as waste sorting, to long-term work with manufacturing and transport. The company’s work on the digitization of paper-based systems has continued, which also contributes to reduced paper consumption and storage volumes.
From an environmental perspective, the products in the CERAMENT platform have many advantages. The main component of the products is ceramic materials, which are produced in processes that do not cause harmful environmental impacts, such as pollution or hazardous waste. The ceramic material in powder form is mixed with a water-based liquid, which does not contain organic solvents. This means that the product is also safe for the healthcare professional who handles it. Our development laboratory in Lund is regularly checked by the environmental administration in Lund municipality with regards to the handling of chemicals and waste.
Our production is undertaken by contract manufacturers. Suppliers are carefully selected and monitored in alignment with our quality management system, and high demands are placed on their compliance with current regulations. Where possible, priority is given to suppliers who carry out active environmental work. BONESUPPORT’s main contract manufacturer is certified according to the international standard ISO 14001. All materials and components are carefully controlled by BONESUPPORT. Production takes place in cleanrooms, a strictly controlled environment without pollution.
AGENDA 2030 AND THE 17 SUSTAINABLE DEVELOPMENT GOALS
Agenda 2030 consists of 17 Sustainable Development Goals (SDGs) aimed at eradicating poverty, halting climate change and creating peaceful and safe societies. BONESUPPORT has identified below SDGs as being the most essential to the business and where BONESUPPORT has the greatest opportunity to influence. The sustainability working group continues to work to set targets for future improvements within these SDGs.
|ESG dimension (UN’s global sustainable development goals)||Category||Goal2022||Result 2022||Goal 2023|
|Social (3, 12)||Product/patient safety||Zero-vision product recalls||No product recalls||Zero-vision product recalls|
|Social (3)||Employee turnover||6% +/- 2%||On target
|6% +/- 2%|
|Social (3,5,8)||Puls survey||Objectives Leadership, Culture and Teamwork OLCT score > 7.8||Well above target||Objectives Leadership, Culture and Teamwork OLCT score > 7.8|
|Environmental (12)||Environment||> 5 A-suppliers certified according to ISO 14001||6 suppliers certified according to ISO 14001||11 A-suppliers certified|
|Governance (16)||Code of conduct||Zero-vision regarding the occurrence of corruption, bribery or fraud or related investigations||No instance of corruption, bribery or fraud or related investigations||Zero-vision regarding the occurrence of corruption, bribery or fraud or related investigations|
|Digitization||> 1 additional document category digitized||3||NA 2023|
|Environmental (12),||Science Based Targets||Commit to scope 1 & scope 2|
2022 Nasdaq ESG Transparency Partner Certification
BONESUPPORT is certified as a Nasdaq ESG Transparency Partner. Nasdaq uses this certification to signal engagement in market transparency and in raising environmental standards. The Nasdaq ESG Matrix includes data points from Environmental, Social, Corporate Governance, and Future Sustainability Goals.
|Topic||BONESUPPORT Reference Procedure||BONESUPPORT Reference Number||Available||Control mechanisms|
|Anti-bribery and anti-corruption||Code of conduct, Global HR Handbook||Policy-010 revision 4, Policy-009 revision 2||Webpage, internal||Yearly documented retraining, KPI|
|Business Continuity||Business Continuity Policy||Policy-023 revision 2||Internal||Yearly documented retraining|
|Business Ethics||Code of conduct, Global HR Handbook||Policy-010 revision 4, Policy-009 revision 2||Webpage, internal||Yearly documented retraining, KPI|
|Environment||Environmental Policy||Policy-020 revision 1||Internal||Supplier audits, KPI|
|Compensation||Global HR handbook, Bonus Policy||Policy-009 revision 2, Policy-019 revision 4||Internal||Yearly documented retraining|
|Supplier management||Supplier Selection, Evaluation and Monitoring||SOP0601 revision 29||Internal||Extensive Supplier Audit Program|
|Social Media||Covered in Global HR Handbook||Policy-009 revision 2||Internal||Yearly documented retraining|
|Diversity and inclusion||Covered in Code of conduct||Policy-010 revision 4||Webpage||Yearly documented retraining, PULS survey|
|Employee competence and development||Training of Personnel||SOP0301 revision 7||Internal||Internal audits, Performance and Potential assessments|